Polymerizable thioureas as innovative reducing agents for self-cured and dual-cured dental materials.

Dent Mater

Ivoclar Vivadent AG, Bendererstrasse 2, FL-9494 Schaan, Liechtenstein. Electronic address:

Published: July 2022

Objective: To evaluate polymerizable acylthioureas as reducing agents in two-component dental materials.

Methods: Acylthioureas 1 and 2 were synthesized and characterized by H and C NMR spectroscopy. Self-cured composites based on the redox initiator system cumene hydroperoxide/acylthiourea 1 or 2/copper(II) acetylacetonate were formulated. Various amounts of cumene hydroperoxide, acylthiourea and copper(II) acetylacetonate were used. An equimolar cumene hydroperoxide/acylthiourea ratio was selected for each self-cured composite. The reactivity and the final double-bond conversions obtained with these two-component materials was assessed using RT-FTIR spectroscopy. The flexural strength and modulus were measured using a three-point bending setup, after storage of the specimens for 45 min at 37 °C (dry) and for 24 h in water at 37 °C. The working time of each composite was determined using an oscillating rheometer.

Results: Acylthioureas 1 and 2 were synthesized in three to four steps. In combination with cumene hydroperoxide and copper(II) acetylacetonate, both prepared compounds were found to be effective reducing agents. The higher the amount of cumene hydroperoxide and acylthiourea in the self-cured composite, the higher the flexural modulus and the faster the polymerization (lower working times). Similarly, it was shown that increased copper(II) acetylacetonate amounts result in an acceleration of the curing as well as in an improvement of the mechanical properties. The self-cured composite containing 1.25 wt% of cumene hydroperoxide in the monomer mixture of the first paste and 2.00 wt% of acylthiourea 1 in the monomer mixture of the second one provided excellent mechanical properties as well as an optimal working time.

Significance: Polymerizable acylthioureas can be used as reducing agents in two-component dental materials. Due to the presence of the methacrylate group, such structures should be efficiently incorporated into the network during polymerization and should not leach out of the composite after curing. As a result, such dental materials are not expected to exhibit bitterness properties.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dental.2022.04.027DOI Listing

Publication Analysis

Top Keywords

reducing agents
16
cumene hydroperoxide
16
dental materials
12
copperii acetylacetonate
12
self-cured composite
12
polymerizable acylthioureas
8
acylthioureas reducing
8
agents two-component
8
two-component dental
8
acylthioureas synthesized
8

Similar Publications

Background: Enterovirus 71 (EV71) is one of the major causative agents of hand, foot, and mouth disease (HFMD), and can cause severe cerebral complications and even fatality in children younger than 5 years old. However, there is no specific medication for EV71 infection in clinical practice. Our previous studies had identified the 6-thioguanine (6-TG), an FDA-approved anticancer drug, as a potential antiviral agent, but its anti-EV71 activity is largely unknown, therefore, we aim to explore the antiviral effect of 6-TG on EV71.

View Article and Find Full Text PDF

Introduction: Inhalers are critical in asthma treatment, and inappropriate inhaler use leads to poor asthma outcomes. In adults and adolescents, dry powder inhalers (DPIs) are safe and effective alternatives to mainstay pressurised metered dose inhalers and could bridge the asthma care gap while also reducing the environmental burden of asthma care. Despite being licensed for use in ages 5 years old and older, the evidence for clinical effectiveness is less clear for patients between ages 5 and 12 years.

View Article and Find Full Text PDF

Introduction: Surgical site infections (SSIs) are the second leading cause of healthcare-associated infections in Europe with the highest rates being reported in colorectal surgery (ranging from 9% to 30%). Surgical antibiotic prophylaxis (SAP) is one of the most efficient measures for SSI prevention and should be started before surgical incision. Cefoxitin is an antibiotic widely used as SAP for colorectal surgery, but its continuous administration is currently the subject of debate due to its potential pharmacokinetic advantages.

View Article and Find Full Text PDF

Chemoprevention Strategies for Precancerous Gastric Lesions Beyond Helicobacter pylori Eradication.

QJM

January 2025

Peking University Traditional Chinese Medicine Clinical Medical School (Xiyuan), Peking University Health Science Center, Beijing, 100091, People's Republic of China.

Gastric cancer (GC) is a significant global health challenge, particularly in high-incidence regions like East Asia. Despite improvements in screening and treatment, the progressive nature of precancerous lesions-such as atrophic gastritis, intestinal metaplasia, and dysplasia-necessitates effective prevention strategies. This review evaluates the role of chemoprevention in GC, focusing on agents designed to target these precancerous lesions.

View Article and Find Full Text PDF

Chalcogen dihydrobenzofuran compounds as potential neuroprotective agents: an in vitro and in silico biological investigation.

Biochimie

January 2025

Laboratory of Biochemistry and Molecular Neuropharmacology (LABIONEM), Graduate Program in Biochemistry and Bioprospecting (PPGBBio), Chemical, Pharmaceutical, and Food Sciences Center (CCQFA), Federal University of Pelotas (UFPel), 96010-900 RS, Brazil. Electronic address:

Oxidative stress arises from an imbalance between reactive species (RS) production and the antioxidant defense, increasing the brain susceptibility to neurodegenerative and psychiatric diseases. Besides, changes in the expression or activity of neurotransmitter metabolism enzymes, such as monoamine oxidases (MAO), are also associated with mental disorders, including depression. Considering this, antioxidant and MAO-A activity inhibitory potential of six 2,3-chalcogenodihydrobenzofurans (2,3-DHBF) was investigated through in vitro and in silico tests.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!